Distribution of Carbapenemase Genes among Carbapenem-Non-Susceptible <i>Acinetobacter baumanii</i> Blood Isolates in Indonesia: A Multicenter Study

• Main Authors: Dewi Anggraini (Author), Dewi Santosaningsih (Author), Yulia Rosa Saharman (Author), Pepy Dwi Endraswari (Author), Cahyarini Cahyarini (Author), Leli Saptawati (Author), Zinatul Hayati (Author), Helmia Farida (Author), Cherry Siregar (Author), Munawaroh Pasaribu (Author), Heriyannis Homenta (Author), Enty Tjoa (Author), Novira Jasmin (Author), Rosantia Sarassari (Author), Wahyu Setyarini (Author), Usman Hadi (Author), Kuntaman Kuntaman (Author)
• Format: Book
• Published: MDPI AG, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/antibiotics11030366; 2079-6382
• Keywords: infectious disease; <i>Acinetobacter baumannii</i>; CNSAB; carbapenemase gene; resistant factor; Indonesia; Therapeutics. Pharmacology; RM1-950
• Source: Antibiotics, Vol 11, Iss 3, p 366 (2022)

Carbapenem non-susceptible <i>Acinetobacter baumannii</i> (CNSAB) is an important pathogen that causes nosocomial bacteremia among critically ill patients worldwide. The magnitude of antibiotic resistance of <i>A. baumanii</i> in Indonesia is expected to be significant; however, the data available are limited. The aim of this study was to analyze the genetic profiles of CNSAB isolates from patients with bacteremia in Indonesia. CNSAB isolates from blood cultures of bacteremia patients in 12 hospitals in Indonesia were included. The blood cultures were conducted using the BacT/Alert or BACTEC automated system. The CNSAB were identified with either Vitek 2 system or Phoenix platform followed by a confirmation test using a multiplex polymerase chain reaction (PCR) assay, targeting the specific gyrB gene. The carbapenemase genes were detected by multiplex PCR. In total, 110 CNSAB isolates were collected and were mostly resistant to nearly all antibiotic classes. The majority of CNSAB isolates were susceptible to tigecycline and trimethoprim-sulfamethoxazole (TMP-SMX), 45.5% and 38.2%, respectively. The <i>bla</i>_OXA-51-like gene was identified in all CNSAB isolates. Out of the total, 83.6% of CNSAB isolates had <i>bla</i>_OXA-23-like gene, 37.3% <i>bla</i>_OXA-24-like gene, 4.5% <i>bla</i>_NDM-1 gene, 0.9% <i>bla</i>_IMP-1 gene, and 0.9% <i>bla</i>_VIM gene. No <i>bla</i>_OXA-48-like gene was identified. The <i>bla</i>_OXA-23-like gene was the predominant gene in all except two hospitals. The presence of the <i>bla</i>_OXA-24-like gene was associated with resistance to tigecycline, amikacin, TMP-SMX and cefoperazone-sulbactam, while <i>bla</i>_OXA-23-like gene was associated with resistance to TMP-SMX and cefoperazone-sulbactam. In conclusion, the <i>bla</i>_OXA-23-like gene was the predominant gene among CNSAB isolates throughout Indonesia. A continuous national surveillance system needs to be established to further monitor the genetic profiles of CNSAB in Indonesia.